Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

Abstract:
No abstract specified

SEEK ID: https://fairdomhub.org/publications/524

DOI: 10.1038/s41422-020-0305-x

Projects: COVID-19 Disease Map

Publication type: Journal

Journal: Cell Research

Citation: Cell Res 30(4):343-355

Date Published: 1st Apr 2020

URL: http://www.nature.com/articles/s41422-020-0305-x

Registered Mode: imported from a bibtex file

Authors: Shuai Xia, Meiqin Liu, Chao Wang, Wei Xu, Qiaoshuai Lan, Siliang Feng, Feifei Qi, Linlin Bao, Lanying Du, Shuwen Liu, Chuan Qin, Fei Sun, Zhengli Shi, Yun Zhu, Shibo Jiang, Lu Lu

Help
help Submitter
Citation
Xia, S., Liu, M., Wang, C., Xu, W., Lan, Q., Feng, S., Qi, F., Bao, L., Du, L., Liu, S., Qin, C., Sun, F., Shi, Z., Zhu, Y., Jiang, S., & Lu, L. (2020). Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Research, 30(4), 343–355. https://doi.org/10.1038/s41422-020-0305-x
Activity

Views: 756

Created: 8th Apr 2020 at 22:14

help Tags

This item has not yet been tagged.

help Attributions

None

Related items

Powered by
(v.1.11.1)
Copyright © 2008 - 2021 The University of Manchester and HITS gGmbH

By continuing to use this site you agree to the use of cookies